The Pfizer Clinical Research Unit in New Haven is seeking healthy volunteers for Part 3 of a COVID-19 clinical trial that will look at the effects and metabolism of multiple doses of the study drug.
COVID-19 is the illness resulting from the novel coronavirus SARS-CoV-2. Millions of people worldwide have been impacted by this illness. Despite efforts to vaccinate against the virus, treatments are still needed for those who become ill to aid in their recovery.
Read more about this study below and see how you can make a difference as a healthy volunteer.
Who may participate
Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.
What to expect
All of the study procedures will be clearly explained to you during screening and can be viewed by downloading the informed consent form.
Interested in participating?
Complete and submit this form, and a Pfizer New Haven Clinical Research Unit (PCRU) representative will contact you. Please note: volunteers completing this form must be able to read and speak English at an 8th grade level.
You may also call 1-800-254-6398 and speak with a PCRU representative to learn more.
For Japanese language assistance only, please call 1-833-711-9984. We apologize, our representatives cannot take calls in languages other than English or Japanese at this time.
The personal data gathered here will be collected, processed, and maintained in a confidential manner. Your information will be stored in our research unit’s database. We may use this information to invite you to participate in current and future clinical studies at the PCRU. You will have full access to your records at the Pfizer New Haven Clinical Research Unit and the opportunity to correct them if necessary.